Case study 1
Can we enter Europe only by our own products in the pipeline?
Pharmaceutical company A is developing two compounds (Phase 2). We hired a consultant to investigate whether only these two product candidates could enter Europe. We heard the opinions of 20 opinion doctors, insurance reimbursement, regulatory affairs, marketing experts, identified data packages necessary for maximizing product value, and made use of it in the development plan. Also, in order to improve the efficiency of sales, we set up a strategy to build a sales network dedicated to hospitals. As a result, the criteria for decision-making for entry into Europe have been clarified. Development was completed, and entry into Europe succeeded.